Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 496 entries
View as:

A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00382512 Org: User:
Start: 05/31/03 End: - Due: -

A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00781443 Org: User:
Start: 12/31/08 End: - Due: -

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00091663 Org: User:
Start: 08/31/04 End: 08/31/05 Due: 08/31/06

A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)

Phase: N/A Priority: Normal
NCT ID: NCT00480831 Org: User:
Start: 06/30/07 End: 08/31/10 Due: 08/31/11

A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications

Phase: N/A Priority: Normal
NCT ID: NCT04353661 Org: User:
Start: 11/16/21 End: 06/29/23 Due: 06/29/24

A Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Divarasib in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06690138 Org: User:
Start: 11/15/24 End: 02/11/25 Due: 02/11/26

Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01461317 Org: User:
Start: 11/29/11 End: 08/07/16 Due: 08/07/17

A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01287091 Org: User:
Start: 10/14/10 End: 02/03/11 Due: 02/03/12

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01359696 Org: User:
Start: 07/11/11 End: 05/29/14 Due: 05/29/15

A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01455493 Org: User:
Start: 12/31/11 End: 01/31/14 Due: 01/31/15

A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00109265 Org: User:
Start: 05/31/01 End: 10/31/02 Due: 10/31/03

A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00299130 Org: User:
Start: 10/31/05 End: 07/31/13 Due: 07/31/14

A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00252135 Org: User:
Start: 06/30/04 End: 11/30/11 Due: 11/30/12

Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)

Phase: N/A Priority: Normal
NCT ID: NCT01366131 Org: User:
Start: 06/30/11 End: - Due: -

A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g

Phase: N/A Priority: Normal
NCT ID: NCT00109252 Org: User:
Start: 01/31/02 End: 04/30/03 Due: 04/30/04

Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E

Phase: N/A Priority: Normal
NCT ID: NCT01586195 Org: User:
Start: 10/31/11 End: 04/30/15 Due: 04/30/16

A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01992653 Org: User:
Start: 11/29/13 End: 12/19/18 Due: 12/19/19

A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)

Phase: N/A Priority: Normal
NCT ID: NCT00318136 Org: User:
Start: 09/30/05 End: 07/31/09 Due: 07/31/10

A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)

Phase: N/A Priority: Normal
NCT ID: NCT00097617 Org: User:
Start: 03/31/02 End: 07/31/10 Due: 07/31/11

A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06372574 Org: User:
Start: 09/30/24 End: 02/01/28 Due: 02/01/29

An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT03407482 Org: User:
Start: 01/09/18 End: 11/20/19 Due: 11/20/20

Tenecteplase in Stroke Patients Between 4.5 and 24 Hours

Phase: N/A Priority: Normal
NCT ID: NCT03785678 Org: User:
Start: 03/02/19 End: 02/28/23 Due: 02/28/24

A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib

Phase: N/A Priority: Normal
NCT ID: NCT01772290 Org: User:
Start: 02/28/13 End: 05/31/13 Due: 05/31/14

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03650413 Org: User:
Start: 01/14/19 End: 07/12/22 Due: 07/12/23

A Study to Evaluate the Effect of a Proton-Pump Inhibitor (Rabeprazole) on the Relative Bioavailability of Cobimetinib in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01277718 Org: User:
Start: 01/31/11 End: 02/28/11 Due: 02/28/12